SCMU
ELV icon

Steadfast Capital Management (UK)’s Elevance Health ELV Stock Holding History

Steadfast Capital Management (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,320
Closed -$4.58M – 10
2022
Q1 		$4.58M Buy
9,320
+1,079
+13% +$493K 6.4% 4
2021
Q4 		$3.82M Buy
8,241
+2,817
+52% +$1.19M 4.59% 8
2021
Q3 		$2.02M Buy
+5,424
New +$2.06M 2.38% 21

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Steadfast Capital Management (UK)'s ELV Position: Q2 2022 in Review

Steadfast Capital Management (UK) sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 9,320 shares — an estimated $4.58M sold.

Steadfast Capital Management (UK) first reported a position in ELV in Q3 2021 and held it in 3 quarters. The position peaked at $4.58M in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Steadfast Capital Management (UK) reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Steadfast Capital Management (UK) sold 9,320 Elevance Health shares in Q2 2022, an estimated $4.58M.
  • Steadfast Capital Management (UK) first reported a position in Elevance Health in Q3 2021 and held it in 3 quarters.
  • Steadfast Capital Management (UK)'s Elevance Health position peaked at $4.58M in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Steadfast Capital Management (UK)'s 13F filing for Q2 2022.